Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Explore various methods to create passive income streams that can help you pay off debt. Start making money while you sleep!
22,771 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Iran has quietly formalized yuan-based fees for ships passing the Strait of Hormuz as U.S. forces position nearby. Th...
Policymakers are weighing tax shifts that could touch luxury spending by the ultra-wealthy. Investors watch designer ...
Analysts issued fresh upgrades on a slate of big-name stocks as earnings season continues. Applied Materials, Devon E...
Saudi Aramco’s CEO cautioned that oil markets may not normalize until 2027 as Strait of Hormuz disruptions persist, i...
SharpLink reveals a hefty Q1 loss tied to unrealized Ethereum markdowns, prompting a debate over Galaxy Digital's fun...
The 2027 COLA estimate has jumped to 3.2% from 1.2%, aided by March inflation and higher energy prices. Retirees face...
Nu Holdings signals growing resilience as it posts a record Q1. This deep dive explains what the results mean for NU ...
A fresh look at history shows disciplined buyers beat market timers over lengthy, stagnant periods. The counterintuit...
Gas prices have surged 51% since february, pushing budgets to the limit as Americans cut back on clothes, gadgets, an...
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Williams-Sonoma has long been a fixture in American homes. This article breaks down why williams-sonoma: strong conte...